Raid Aljumaily Selected Research

Pneumonia (Pneumonitis)

1/2018	Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.
1/2014	Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raid Aljumaily Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 04/2013
4	Disease Progression 10/2020 - 06/2011
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 01/2021
2	Adenocarcinoma 01/2024 - 01/2021
2	Anemia 01/2021 - 01/2014
2	Neutropenia 01/2021 - 01/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2014
2	Carcinoma (Carcinomatosis) 10/2020 - 01/2018
2	Thrombocytopenia (Thrombopenia) 11/2019 - 01/2014
2	Fatigue 11/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 04/2013
2	Pneumonia (Pneumonitis) 01/2018 - 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Multiple Myeloma 01/2022
1	Residual Neoplasm 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020
1	Renal Insufficiency (Renal Failure) 10/2020
1	Small Cell Carcinoma 11/2019
1	Communicable Diseases (Infectious Diseases) 11/2019
1	Obesity 01/2019
1	Asthenia 01/2018
1	Radiation Pneumonitis 01/2014
1	Esophagitis 01/2014
1	Fever (Fevers) 01/2014
1	Neoplasm Micrometastasis 01/2014
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 06/2011
1	Prostatic Neoplasms (Prostate Cancer) 06/2011
1	Pain (Aches) 06/2011

Drug/Important Bio-Agent (IBA)

3	pegilodecakinIBA 01/2021 - 11/2019
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2021 - 04/2013
2	trilaciclibIBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2020 - 04/2013
2	avelumabIBA 10/2020 - 01/2018
2	PlatinumIBA 10/2020 - 01/2018
1	LCL161IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	cemiplimabIBA 01/2021
1	prexasertibIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	GlucocorticoidsIBA 12/2020
1	AlbuminsIBA 10/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2020
1	AntibodiesIBA 10/2020
1	LigandsIBA 10/2020
1	pembrolizumabIBA 11/2019
1	NivolumabIBA 11/2019
1	LeptinIBA 01/2019
1	navicixizumabIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Therapeutic UsesIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Gemcitabine FDA Link 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	Carboplatin (JM8)FDA LinkGeneric 01/2014
1	Bevacizumab (Avastin)FDA Link 04/2013
1	matrigelIBA 04/2013
1	Metalloproteases (Metalloproteinases)IBA 04/2013
1	Radioisotopes (Radionuclides)IBA 06/2011
1	Diphosphonates (Bisphosphonates)IBA 06/2011
1	RANK LigandIBA 06/2011

Therapy/Procedure

4	Therapeutics 01/2024 - 06/2011
2	Adjuvant Chemotherapy 01/2024 - 01/2014
2	Radiotherapy 01/2024 - 01/2014
1	Stem Cell Transplantation 01/2022
1	Transplantation 01/2022
1	Immunotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Intravenous Infusions 01/2018